Trial Profile
Activity, efficacy and safety of nab-paclitaxel and gemcitabine in elderly advanced pancreatic cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Feb 2015 New trial record